Hyperthermia cancer treatment market to reach $0.41 billion by 2030

The hyperthermia cancer treatment market is projected to grow from $0.29 billion in 2025 to $0.41 billion by 2030, as cancer rates rise and more providers pair heat therapy with radiation, chemotherapy and other treatments. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The hyperthermia cancer treatment market is expanding as cancer cases rise worldwide and clinicians look for therapies that can improve outcomes without adding as much systemic toxicity. - The market’s projected growth suggests more demand for devices and protocols that support combination cancer care.

What happened: - The Business Research Company said the hyperthermia cancer treatment market is expected to rise from $0.29 billion in 2025 to $0.31 billion in 2026. - The same report projects the market will reach $0.41 billion by 2030, implying a 6.9% CAGR during the forecast period. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

The details: - Hyperthermia cancer treatment uses controlled heat to damage or kill cancer cells. - Hyperthermia is commonly used with radiation, chemotherapy or immunotherapy to improve treatment effectiveness. - Treatment can be delivered locally, regionally or to the whole body depending on cancer type and location. - The report links recent growth to rising global cancer rates, wider use of radiation and chemotherapy, stronger hospital oncology infrastructure, more clinical research and greater awareness of advanced cancer care. - The report says future growth will be driven by precision oncology, personalized treatment, broader use of combination therapies, better non-invasive and targeted technologies, healthcare expansion in emerging markets and more investment in cancer-care devices. - The report highlights several trends, including image-guided hyperthermia systems, AI-based treatment planning, minimally invasive localized heating, and real-time temperature monitoring with feedback controls. - A free sample report is available here. - The full report is available here.

Between the lines: - The report points to a market that is still small in dollar terms, but gaining relevance as cancer care shifts toward personalized and multimodal treatment. - The emphasis on image guidance, AI planning and real-time monitoring suggests competition will likely center on accuracy, safety and integration with existing oncology workflows. - The report cites National Library of Medicine data from October 2025 showing global cancer incidence is expected to rise 60.7% from 2024 to 2050, from 19 million to 30.5 million new cases.

What’s next: - More clinical adoption is likely as providers look for ways to make radiation and chemotherapy more effective. - Market growth will likely track healthcare expansion in emerging markets and investment in new cancer-treatment devices. - Regional momentum in Asia-Pacific could narrow the gap with North America if cancer prevalence and infrastructure spending continue to rise.

The bottom line: - Hyperthermia is moving from a niche adjunct therapy toward a more established part of combination cancer treatment, supported by rising cancer incidence and steady technology upgrades.